F-star Therapeutics PEG Ratio

F-star Therapeutics (FSTX) currently reports a PEG ratio of -5.32. That is below the Healthcare sector average of 11.64. Use the charts on this page to explore F-star Therapeutics's PEG ratio history and peer comparisons.

F-star Therapeutics's PEG ratio of -5.32 is lower than the Healthcare sector average of 11.64. That is roughly 145.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates F-star Therapeutics's market price to a fundamental measure such as earnings, sales, or book value. At -5.32, FSTX can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of -5.32, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 11.64. From there, open related valuation or income-statement pages for F-star Therapeutics, and consider following FSTX for alerts when major investors trade the stock.

F-star Therapeutics is classified in the Healthcare sector. On PEG ratio, it currently shows -5.32 versus a sector average near 11.64. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing FSTX with unrelated industries.